Somatic and germline mutations of RUNX1 cause ~10% of acute myeloid leukemia (AML) as well as preleukemic diseases with predisposition to AML, such as myelodysplastic syndrome (MDS) (~10%) [16–18]. This evidence concerns the gene RUNX1 and myelodysplastic syndrome.